XML 34 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue:      
Total revenue $ 0 $ 886 $ 2,329
Operating expenses:      
Research and development [1] 162,790 89,504 58,579
General and administrative 45,776 39,946 28,531
Acquired in-process research and development 0 130,188 0
Gain on sale of in-process research and development asset 0 (16,449) 0
Total operating expenses 208,566 243,189 87,110
Loss from operations (208,566) (242,303) (84,781)
Other income (expense):      
Interest income 21,312 6,147 837
Other expense, net (20,713) (19,130) (7)
Total other income (expense) 599 (96,513) 830
Loss before income tax expense (207,967) (338,816) (83,951)
Income tax (expense) benefit (51) 26 136
Net loss (208,018) (338,790) (83,815)
Series A Non-Voting Convertible Preferred Stock      
Other income (expense):      
Net loss $ (47,624) $ (239,158) $ 0
Net loss per share, basic (in dollars per share) $ (127.21) $ (550.28) $ 0
Net loss per share, diluted (in dollars per share) $ (127.21) $ (550.28) $ 0
Weighted-average common shares outstanding, basic (in shares) 374,387 434,612 0
Weighted-average common shares outstanding, diluted (in shares) 374,387 434,612 0
Series B Non-Voting Convertible Preferred Stock      
Other income (expense):      
Net loss $ (10,839) $ (4,749) $ 0
Net loss per share, basic (in dollars per share) $ (127.21) $ (550.29) $ 0
Net loss per share, diluted (in dollars per share) $ (127.21) $ (550.29) $ 0
Weighted-average common shares outstanding, basic (in shares) 85,208 8,630 0
Weighted-average common shares outstanding, diluted (in shares) 85,208 8,630 0
Common Stock      
Other income (expense):      
Net loss $ (149,555) $ (94,883) $ (83,815)
Net loss per share, basic (in dollars per share) $ (3.18) $ (13.76) $ (24.86)
Net loss per share, diluted (in dollars per share) $ (3.18) $ (13.76) $ (24.86)
Weighted-average common shares outstanding, basic (in shares) 47,027,638 6,897,065 3,371,231
Weighted-average common shares outstanding, diluted (in shares) 47,027,638 6,897,065 3,371,231
Forward Contract Liability      
Other income (expense):      
Change in fair value of forward contract liability $ 0 $ (83,530) $ 0
Development fee and royalty      
Revenue:      
Total revenue $ 0 $ 886 $ 2,329
[1] Includes $41.2 million and $48.5 million in related party expenses for the years ended December 31, 2024 and December 31, 2023, respectively, and no related party expenses for the year ended December 31, 2022.